Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
After finishing at $5.39 in the prior trading day, Aldeyra Therapeutics Inc (NASDAQ: ALDX) closed at $5.44, up 0.93%. In other words, the price has increased by $0.93 from its previous closing price. On the day, 0.74 million shares were traded. ALDX stock price reached its highest trading level at $5.65 during the session, while it also had its lowest trading level at $5.391.
Ratios:
Our goal is to gain a better understanding of ALDX by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.82 and its Current Ratio is at 2.82. In the meantime, Its Debt-to-Equity ratio is 0.28 whereas as Long-Term Debt/Eq ratio is at 0.00.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 13 ’25 when Alfieri Michael bought 2,500 shares for $5.30 per share. The transaction valued at 13,250 led to the insider holds 2,500 shares of the business.
Machatha Stephen sold 22,073 shares of ALDX for $113,713 on Aug 11 ’25. The Chief Development Officer now owns 221,799 shares after completing the transaction at $5.15 per share. On Aug 12 ’25, another insider, Machatha Stephen, who serves as the Officer of the company, bought 22,074 shares for $5.26 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALDX now has a Market Capitalization of 326647520 and an Enterprise Value of 259468256.
Stock Price History:
The Beta on a monthly basis for ALDX is 0.78, which has changed by 0.011152387 over the last 52 weeks, in comparison to a change of 0.15222645 over the same period for the S&P500. Over the past 52 weeks, ALDX has reached a high of $7.20, while it has fallen to a 52-week low of $1.14. The 50-Day Moving Average of the stock is 23.05%, while the 200-Day Moving Average is calculated to be 20.16%.
Shares Statistics:
The stock has traded on average 1.03M shares per day over the past 3-months and 887060 shares per day over the last 10 days, according to various share statistics. A total of 60.05M shares are outstanding, with a floating share count of 58.17M. Insiders hold about 2.87% of the company’s shares, while institutions hold 57.81% stake in the company. Shares short for ALDX as of 1753920000 were 5034432 with a Short Ratio of 4.90, compared to 1751241600 on 4465802. Therefore, it implies a Short% of Shares Outstanding of 5034432 and a Short% of Float of 8.66.
Earnings Estimates
The stock of Aldeyra Therapeutics Inc (ALDX) is currently being evaluated by 4.0 analysts who are actively contributing to its market rating.The consensus estimate for the next quarter is -$0.18, with high estimates of -$0.16 and low estimates of -$0.2.
Analysts are recommending an EPS of between -$0.62 and -$0.7 for the fiscal current year, implying an average EPS of -$0.66. EPS for the following year is $0.59, with 4.0 analysts recommending between $1.67 and -$0.44.
Revenue Estimates
Based on 6 analysts’ estimates, the company’s revenue will be $79.04M in the next fiscal year. The high estimate is $168M and the low estimate is $16M.
